SARAH FLORENCE: Open Payments
NPI 1124250089 · CYNTHIANA, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$675 in 34 payments from 16 companies in 2025. Trend: 2023 $573 · 2024 $718 · 2025 $675
Food & beverage: $675
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 6 | $112 |
| Novo Nordisk Inc | 4 | $87 |
| PFIZER INC. | 4 | $67 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $62 |
| Dexcom, Inc. | 2 | $59 |
| Merck Sharp & Dohme LLC | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| SANOFI-AVENTIS U.S. LLC | 2 | $40 |
| Axsome Therapeutics, Inc. | 1 | $32 |
| Verona Pharma, Inc. | 1 | $24 |
Products named: GEMTESA, NURTEC ODT, Kerendia, REXULTI, Dexcom G6 Transmitter, Ozempic, TZIELD, Auvelity.
Industry payments across KY — which companies pay providers there.
